Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials.
D026683:Advisory Committees; D026661:Clinical Trials Data Monitoring Committees; D032802:Committee Membership; D004345:Drug Industry; D026724:Ethical Review; D004989:Ethics; D017041:Ethics Committees; D028744:Ethics Committees, Research; D035082:Federal Government; D006076:Government; D033161:Government Regulation; D017408:Guidelines as Topic; D006805:Human Experimentation; D015337:Multicenter Studies as Topic; D009316:National Institutes of Health (U.S.); D009934:Organization and Administration; D011897:Random Allocation; D012015:Reference Standards; D012107:Research Design; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D014481:United States
Biomedical and Behavioral Research; National Institutes of Health